UNSPSC 51143403: Belladonna/caffeine/ergotamine/pentobarbital

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN105. This VA Drug Class (CN105) classifies this compound as belonging to the group ANTIMIGRAINE AGENTS.

UNSPSC 51143403 Belladonna/caffeine/ergotamine/pentobarbital is a Commodity code representing pharmaceutical and controlled substances, but recent state and local procurement activity under this code shows a mismatch with its nominal scope. The only recent opportunity on file is Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, for naloxone and safe drug deactivation systems — a public health and harm-reduction procurement that falls outside the pharmaceutical compounds nominally described by the code. The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. Vendors were required to include all shipping and delivery costs, comply with drug-free workplace certification and E-Verify requirements, maintain specified insurance coverage, and operate under a two-year initial term with a one-year renewal option subject to a three-month probationary period.

The code shows minimal recent activity and lacks a clear pattern of state and local buying behavior aligned with its formal description. Seminole County, a county-level issuing body in Florida, appears as the only recent buyer on record under this code. The procurement structure, timing, and compliance requirements suggest potential FEMA funding with associated federal oversight, but the code's nominal scope—pharmaceutical alkaloids used historically in ergot-based remedies—bears no relation to the naloxone and drug deactivation systems Seminole County actually procured. Business development professionals should verify whether this code assignment reflects a data-entry error in the original solicitation or whether it genuinely represents state and local buying activity in this pharmaceutical family; the mismatch signals either minimal market activity or a broader cataloging issue that warrants clarification before pursuing opportunities tagged to this code.